GFAP and epilepsy: Gfap, an astrocyte-specific cytoskeleton protein, is used as a marker of reactive astrogliosis during epilepsy [42], [43], and is dramatically up-regulated in animal and human epileptogenic hippocampus [21], [32]–[39].